A panel of experts highlight the burden of Alzheimer’s disease and current unmet needs related to diagnosis and treatment, discuss clinical and payer considerations for the diagnosis and management of AD, and generate discussion around future directions in the diagnosis and treatment.
EP. 1: Alzheimer Disease: Clinical Burden and TreatmentAugust 30th 2021
Key opinion leaders discuss the clinical burden for a patient with Alzheimer disease and enumerate available drug and nondrug treatment options.
EP. 3: Patient Journey to Health Care System and DiagnosisSeptember 7th 2021
Panelists consider at what point in the disease development patients typically access the health care system for diagnosis and treatment.
EP. 4: Increased Prevalence of Alzheimer DiseaseSeptember 8th 2021
Experts in the management of Alzheimer disease consider the increased prevalence of Alzheimer disease in the United States with growing geriatric populations and how the health care system is adapting.
EP. 6: Key Drivers for Health Care Utilization and SpendingSeptember 15th 2021
Key opinion leaders discuss which factors contribute to patients and caregivers deciding to seek health care guidance and assistance for Alzheimer disease.
EP. 7: Diagnostic Process for Individuals With Suspected ADSeptember 20th 2021
A discussion on the typical journey of a patient with Alzheimer disease from initial presentation to proper diagnosis within the health care system.
EP. 8: Goals of AD Therapy With Early DetectionSeptember 22nd 2021
Experts in the management of Alzheimer disease consider the future goals of therapy in tandem with the development of early detection polices.
EP. 11: Developing Policies for Early Biomarker DetectionOctober 4th 2021
Panelists discuss how to craft future policies for early biomarker detection to use developing therapies that target underlying pathophysiology.
EP. 14: The American Brain Foundation: Driving AD Treatment DevelopmentOctober 13th 2021
A member of the American Brain Foundation discusses the organization’s role in the development of Alzheimer disease management and improvement in education.
EP. 15: Disease-Modifying Therapy: Defining ResponseOctober 18th 2021
Expert panelists consider how to define response to disease-modifying therapies and discuss the threshold for treatment ineligibility due to lack of response.